United States · FDA National Drug Code directory
mRESVIA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 80777-345_42531fa9-5b49-4ebe-8117-ce2fd97c0c53
- Product NDC
- 80777-345
- Form
- SUSPENSION
- Composition / generic term
- Respiratory Syncytial Virus Vaccine
- Labeler
- Moderna US, INC.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20240531
- Source listing expiry
- 20271231
Source-listed ingredients
- RNA-100-AR02 — 50 ug/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 SYRINGE in 1 CARTON (80777-345-61) / .5 mL in 1 SYRINGE (80777-345-01) · 80777-345-61
- 1 SYRINGE in 1 CARTON (80777-345-62) / .5 mL in 1 SYRINGE (80777-345-01) · 80777-345-62
- 2 SYRINGE in 1 CARTON (80777-345-63) / .5 mL in 1 SYRINGE (80777-345-01) · 80777-345-63
- 2 SYRINGE in 1 CARTON (80777-345-89) / .5 mL in 1 SYRINGE (80777-345-01) · 80777-345-89
- 1 SYRINGE in 1 CARTON (80777-345-90) / .5 mL in 1 SYRINGE (80777-345-01) · 80777-345-90
- 10 SYRINGE in 1 CARTON (80777-345-96) / .5 mL in 1 SYRINGE (80777-345-01) · 80777-345-96
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →